Baidu
map

Radiology:三维深卷积神经网络使HCM心肌瘢痕自动定量成为可能

2021-05-14 shaosai MedSci原创

肥厚性心肌病(HCM)是最常见的遗传性心肌病,是年轻人和运动员心源性猝死的主要原因。心脏MRI的定量晚期钆增强(LGE)是预测HCM患者预后的重要影像学手段。

肥厚性心肌病(HCM)是最常见的遗传性心肌病,是年轻人和运动员心源性猝死的主要原因。心脏MRI的定量晚期钆增强(LGE)是预测HCM患者预后的重要影像学手段。大量研究表明LGE的存在与长期预后相关,LGE在HCM中的定量价值也在多项研究中证明。在HCM患者的临床护理中,稳定且可重复的疤痕量化可以显著提高LGE体积作为预后成像标记的应用。然而,目前临床上定量LGE瘢痕依赖于繁琐和耗时的二维(2D)图像手工分析来识别LGE的区域。此外,读取器、心脏MRI中心和分析核心实验室之间的差异降低了瘢痕定量的可重复性,并阻碍了其临床应用。

近日,发表在Radiology杂志的一项研究开发并验证了一种基于三维(3D)卷积神经网络的HCM患者LGE瘢痕自动定量方法,为临床便捷、快速的自动量化LGE瘢痕提供了技术支持。

本研究回顾性评估了2001年11月至2011年11月在多中心(n = 7)和多厂商(n = 3) HCM研究中获得的LGE MRI数据。采用基于U-Net架构的深度3D CNN对LGE疤痕进行量化。独立的CNN训练和测试数据集保持4:1的比例。使用Dice相似系数(DSC)、Pearson相关性和Bland-Altman分析,在核心实验室设置下,通过人工疤痕量化评估了每个中心和每个供应商的3D CNN性能。此外,还比较了3D CNN和2D CNN的性能。

本研究包括1073例HCM患者(733名男性;平均年龄49岁±17岁(标准差))。基于CNN的3D量化速度快(0.15秒/张),与人工瘢痕体积量化(r = 0.88, P < .001)和疤痕体积与左室心肌总容积(%LGE)的比值(r = 0.91, P < .001)具有良好的相关性基于CNN的3D量化与人工定量疤痕体积(r = 0.82-0.99, P < .001)和%LGE (r = 0.90-0.97, P < .001)具有强相关性。在识别大瘢痕负担患者(>15%)上,3D CNN的准确率为98%(202/207)(95%置信区间[CI]: 95%,99%)。与3D CNN相比,2D CNN低估了瘢痕体积(r = 0.85, P < .001)和%LGE (r = 0.83, P < .001)。不同厂商3D CNN分割的DSC具有可比性(P = .07),且高于2D CNN (DSC, 0.54±0.26 vs 0.48±0.29;P = .02)。

图1 诊断为肥厚性心肌病的60岁男子的MRI图像。该图显示了所有心脏MRI短轴层面的分割结果。人工(上行)和三维(3D)卷积神经网络(CNN)(下行)分割的心肌(红色)和瘢痕(黄色)轮廓被覆盖在晚期钆增强图像上。本例患者的手工和3D CNN定量瘢痕体积分别为15.3 cm3和12.3 cm3, Dice相似系数为0.77。

 

图2 瘢痕自动分割的评价。瘢痕体积(左栏)和瘢痕体积与左心室心肌总体积之比(右栏)的(a,b)线性回归和(c,d)自动分割与手动分割Bland-Altman图。

综上所述,本文提出的基于三维卷积神经网络(CNN)的MRI晚期钆增强心肌分割可以从多中心图像数据集中快速准确地定量肥厚性心肌病患者的心肌瘢痕。本研究提出的三维量化方法优于二维,并在来自不同供应商的数据集上表现出一致的性能。

原文出处:

Ahmed S Fahmy,Ulf Neisius,Raymond H Chan,et al.Three-dimensional Deep Convolutional Neural Networks for Automated Myocardial Scar Quantification in Hypertrophic Cardiomyopathy: A Multicenter Multivendor Study.DOI:10.1148/radiol.2019190737

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1336992, encodeId=e5ac133699248, content=<a href='/topic/show?id=48f8e12220f' target=_blank style='color:#2F92EE;'>#瘢痕#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71222, encryptionId=48f8e12220f, topicName=瘢痕)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fa82500120, createdName=12498a1cm67暂无昵称, createdTime=Sun May 16 00:17:01 CST 2021, time=2021-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478114, encodeId=b67014e811456, content=<a href='/topic/show?id=f51a8556cc' target=_blank style='color:#2F92EE;'>#HCM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8556, encryptionId=f51a8556cc, topicName=HCM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sun May 16 00:17:01 CST 2021, time=2021-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623113, encodeId=45fe162311301, content=<a href='/topic/show?id=fc1e5130694' target=_blank style='color:#2F92EE;'>#心肌瘢痕#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51306, encryptionId=fc1e5130694, topicName=心肌瘢痕)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=425220488457, createdName=crystal0569, createdTime=Sun May 16 00:17:01 CST 2021, time=2021-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630364, encodeId=9ca31630364be, content=<a href='/topic/show?id=44e0e449217' target=_blank style='color:#2F92EE;'>#神经网络#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74492, encryptionId=44e0e449217, topicName=神经网络)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6ff21497204, createdName=by2016, createdTime=Sun May 16 00:17:01 CST 2021, time=2021-05-16, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1336992, encodeId=e5ac133699248, content=<a href='/topic/show?id=48f8e12220f' target=_blank style='color:#2F92EE;'>#瘢痕#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71222, encryptionId=48f8e12220f, topicName=瘢痕)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fa82500120, createdName=12498a1cm67暂无昵称, createdTime=Sun May 16 00:17:01 CST 2021, time=2021-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478114, encodeId=b67014e811456, content=<a href='/topic/show?id=f51a8556cc' target=_blank style='color:#2F92EE;'>#HCM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8556, encryptionId=f51a8556cc, topicName=HCM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sun May 16 00:17:01 CST 2021, time=2021-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623113, encodeId=45fe162311301, content=<a href='/topic/show?id=fc1e5130694' target=_blank style='color:#2F92EE;'>#心肌瘢痕#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51306, encryptionId=fc1e5130694, topicName=心肌瘢痕)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=425220488457, createdName=crystal0569, createdTime=Sun May 16 00:17:01 CST 2021, time=2021-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630364, encodeId=9ca31630364be, content=<a href='/topic/show?id=44e0e449217' target=_blank style='color:#2F92EE;'>#神经网络#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74492, encryptionId=44e0e449217, topicName=神经网络)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6ff21497204, createdName=by2016, createdTime=Sun May 16 00:17:01 CST 2021, time=2021-05-16, status=1, ipAttribution=)]
    2021-05-16 仁者大医
  3. [GetPortalCommentsPageByObjectIdResponse(id=1336992, encodeId=e5ac133699248, content=<a href='/topic/show?id=48f8e12220f' target=_blank style='color:#2F92EE;'>#瘢痕#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71222, encryptionId=48f8e12220f, topicName=瘢痕)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fa82500120, createdName=12498a1cm67暂无昵称, createdTime=Sun May 16 00:17:01 CST 2021, time=2021-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478114, encodeId=b67014e811456, content=<a href='/topic/show?id=f51a8556cc' target=_blank style='color:#2F92EE;'>#HCM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8556, encryptionId=f51a8556cc, topicName=HCM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sun May 16 00:17:01 CST 2021, time=2021-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623113, encodeId=45fe162311301, content=<a href='/topic/show?id=fc1e5130694' target=_blank style='color:#2F92EE;'>#心肌瘢痕#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51306, encryptionId=fc1e5130694, topicName=心肌瘢痕)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=425220488457, createdName=crystal0569, createdTime=Sun May 16 00:17:01 CST 2021, time=2021-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630364, encodeId=9ca31630364be, content=<a href='/topic/show?id=44e0e449217' target=_blank style='color:#2F92EE;'>#神经网络#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74492, encryptionId=44e0e449217, topicName=神经网络)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6ff21497204, createdName=by2016, createdTime=Sun May 16 00:17:01 CST 2021, time=2021-05-16, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1336992, encodeId=e5ac133699248, content=<a href='/topic/show?id=48f8e12220f' target=_blank style='color:#2F92EE;'>#瘢痕#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71222, encryptionId=48f8e12220f, topicName=瘢痕)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fa82500120, createdName=12498a1cm67暂无昵称, createdTime=Sun May 16 00:17:01 CST 2021, time=2021-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478114, encodeId=b67014e811456, content=<a href='/topic/show?id=f51a8556cc' target=_blank style='color:#2F92EE;'>#HCM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8556, encryptionId=f51a8556cc, topicName=HCM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sun May 16 00:17:01 CST 2021, time=2021-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623113, encodeId=45fe162311301, content=<a href='/topic/show?id=fc1e5130694' target=_blank style='color:#2F92EE;'>#心肌瘢痕#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51306, encryptionId=fc1e5130694, topicName=心肌瘢痕)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=425220488457, createdName=crystal0569, createdTime=Sun May 16 00:17:01 CST 2021, time=2021-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630364, encodeId=9ca31630364be, content=<a href='/topic/show?id=44e0e449217' target=_blank style='color:#2F92EE;'>#神经网络#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74492, encryptionId=44e0e449217, topicName=神经网络)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6ff21497204, createdName=by2016, createdTime=Sun May 16 00:17:01 CST 2021, time=2021-05-16, status=1, ipAttribution=)]

相关资讯

快速掌握肥厚型心肌病的诊治方案,一文读懂!

肥厚型心肌病是临床上较为常见的一种心肌病,因其猝死率高,现逐渐得到各国心血管医师的重视,去年我国公布了最新版《中国成人肥厚型心肌病诊断与治疗指南》(以下简称《指南》),单纯文字描述阻碍了我们迅速掌握指南的精髓,现我通过一例病例与大家共同学习以下这部指南。

Radiology:神经卷积网络自动测量肥厚性心肌病心肌瘢痕体积

心脏MRI增强晚期(LGE)瘢痕体积是预测肥厚性心肌病(HCM)患者预后侧一项重要指标。但由于目前临床尚无标准的测量方法,其临床应用并未被广泛接受。

Circulation:肥厚性心肌病伴左室收缩功能障碍的发生、发展及预后

“终末期”常被用于描述肥厚性心肌病(HCM)伴左室收缩功能障碍(LVSD),定义为左室射血分数<50%。据报道,HCM-LVSD预后较差,但由于其相对罕见,其自然史仍未完

JAHA:肥厚性心肌病患者房颤消融治疗:策略、连续房性心动过速特点和长期结局

AF消融对HCM患者的长期心律控制是有效的,特别是对阵发性AF患者进行肺静脉隔离治疗会取得良好的临床效果。AF消融后的ATs在HCM患者中很常见。

JAHA:肥厚性心肌病患者抑郁症与临床结局之间的关系

抑郁症在HCM患者中很常见。抑郁症的诊断与HCM患者SCD事件和心力衰竭事件的风险增加显著且独立相关。

FDA接受BMS在梗阻性肥厚性心肌病(oHCM)中使用Mavacamten的申请

制药公司BMS近日宣布,美国食品药品监督管理局(FDA)已接受其Mavacamten的新药申请(NDA),Mavacamten是一种针对症状性梗阻性肥厚性心肌病(oHCM)的肌球蛋白抑制剂。

Baidu
map
Baidu
map
Baidu
map